{"id":"NCT00662558","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain","officialTitle":"A Six Week Double-Blind, Randomized, Multicenter Comparison Study Of The Analgesic Effectiveness Of Celecoxib 200 Mg BID Compared To Tramadol Hydrochloride 50 Mg QID In Subjects With Chronic Low Back Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2008-09","completion":"2008-09","firstPosted":"2008-04-21","resultsPosted":"2009-11-23","lastUpdate":"2021-02-21"},"enrollment":802,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Low Back Pain"],"interventions":[{"type":"DRUG","name":"celecoxib","otherNames":[]},{"type":"DRUG","name":"tramadol HCL","otherNames":[]}],"arms":[{"label":"celecoxib","type":"EXPERIMENTAL"},{"label":"tramadol","type":"ACTIVE_COMPARATOR"}],"summary":"To compare the analgesic effectiveness of celecoxib and tramadol in subjects with Chronic Low Back Pain measured by the Numerical Rating Scale (NRS-Pain) at Week 6","primaryOutcome":{"measure":"Treatment Responders Based on the Numerical Rating Scale-Pain (NRS-Pain)","timeFrame":"Week 6 or Early Termination (ET)","effectByArm":[{"arm":"Celecoxib","deltaMin":254,"sd":null},{"arm":"Tramadol HCL","deltaMin":218,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.008"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":60,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3191338&StudyName=A%20Six%20Week%20Study%20Of%20The%20Pain%20Relieving%20Effects%20Of%20Celecoxib%20200%20Mg%20Twice%20Daily%20Compared%20To%20Tramadol%2050%20Mg%20Four%20Times%20Daily%20In%20"]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Nausea","Headache","Dizziness","Somnolence","Constipation"]}}